Expression of RRM1 and RRM2 as a novel prognostic marker in advanced non-small cell lung cancer receiving chemotherapy

Author： Wang Lei Meng Long Wang Xing-wen Ma Guo-yuan Chen Jing-han

ISSN： 1010-4283

Source： Tumor Biology, Vol.35, Iss.3, 2014-03, pp. : 1899-1906

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Prognostic significance of the mRNA expression of ERCC1, RRM1, TUBB3 and TYMS genes in patients with non-small cell lung cancer

Experimental and Therapeutic Medicine, Vol. 10, Iss. 3, 2015-01 ,pp. : 937-941

Spandidos Publications

Access to resources Recommend Favorite

Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 299-305

Spandidos Publications

Access to resources Recommend Favorite

Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients

Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. : 2385-2398

Spandidos Publications

Access to resources Recommend Favorite

EGFR and K-RAS mutations and ERCC1, TUBB3, TYMS, RRM1 and EGFR mRNA expression in nonsmall cell lung cancer: Correlation with clinical response to gefitinib or chemotherapy

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1123-1128

Science Publishers

Access to resources Recommend Favorite

Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 802-806

Science Publishers

Access to resources Recommend Favorite